首页> 外国专利> Screening method of the materials for prevention or treatment of osteoporosis using leptin production in mesenchymal stem cell

Screening method of the materials for prevention or treatment of osteoporosis using leptin production in mesenchymal stem cell

机译:利用间充质干细胞中的瘦素产生预防或治疗骨质疏松症的材料的筛选方法

摘要

the invention mesenchymal stem cells (Mesenchymal stem cell) the prevention or treatment of osteoporosis using a screening method for a substance relates to, and more specifically by measuring the amount of a method for screening a substance for the prevention or treatment of osteoporosis in a short time of leptin (leptin) secreted by MSCs. The screening method of preventive or therapeutic agent for osteoporosis by the mesenchymal stem cell according to the present invention, and screening methods for osteoporosis prevention or health food composition for the improvement is to be selected by the candidate agent for osteoporosis prevention or treatment within about 3 days, at least 10 days or more may be selected as compared with the conventional method used to take significantly increase the efficiency, it is expected that test method may be used for screening a large number of materials in a short time because it is simple. ;
机译:本发明的间充质干细胞(Mesenchymal stem cell,简称间充质干细胞)使用物质的筛选方法来预防或治疗骨质疏松症涉及,更具体地讲,是通过测量在短期内用于预防或治疗骨质疏松的物质的筛选方法的量来进行的。时间由MSC分泌的瘦素(leptin)。根据本发明的通过间充质干细胞的骨质疏松预防或治疗剂的筛选方法,以及用于改善骨质疏松的预防或保健食品组合物的筛选方法,应在约3以下的范围内选择用于骨质疏松的预防或治疗的候选剂。与用于显着提高效率的常规方法相比,可以选择至少10天或更长时间,可以预期,因为其简单,所以测试方法可以用于在短时间内筛选大量材料。 ;

著录项

  • 公开/公告号KR101354826B1

    专利类型

  • 公开/公告日2014-01-27

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20110131255

  • 发明设计人 노민수;

    申请日2011-12-08

  • 分类号G01N33/53;G01N33/74;G01N33/15;C12N5/0775;

  • 国家 KR

  • 入库时间 2022-08-21 15:41:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号